Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00302159
What this trial is testing

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

Who this might be right for
High Grade GliomasBrain Tumors
National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT02569320
What this trial is testing

HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Ohio State University Comprehensive Cancer Center 9
Early research (Phase 1)WithdrawnNCT04639843
What this trial is testing

Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma

Who this might be right for
Adult T-cell Leukemia/LymphomaExtranodal NK-/T-cell Lymphoma, Nasal TypeEnteropathy-Associated T-Cell Lymphoma+2 more
National Cancer Institute (NCI)
Very early researchWithdrawnNCT03263533
What this trial is testing

HDAC Inhibitor Augmentation to Clozapine

Who this might be right for
Schizophrenia
Virginia Commonwealth University
Testing effectiveness (Phase 2)Looking for participantsNCT06709885
What this trial is testing

HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer

Who this might be right for
Colon Adenocarcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06421948
What this trial is testing

Linperlisib Combined With Chidamide in Patients With PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Yanyan Liu 134
Early research (Phase 1)UnknownNCT01175109
What this trial is testing

Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma

Who this might be right for
Chordoma
Deric M Park MD 36
Testing effectiveness (Phase 2)Study completedNCT02836548
What this trial is testing

HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma

Who this might be right for
MelanomaSkin Neoplasms
The Netherlands Cancer Institute 33
Early research (Phase 1)Study completedNCT06049147
What this trial is testing

Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

Who this might be right for
Safety and Pharmacokinetic
Medibiofarma S.L. 72
Testing effectiveness (Phase 2)Ended earlyNCT01000155
What this trial is testing

Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT00621244
What this trial is testing

Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma
Novartis Pharmaceuticals 175
Early research (Phase 1)Study completedNCT00697879
What this trial is testing

Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor
Chroma Therapeutics 40
Large-scale testing (Phase 3)WithdrawnNCT02654405
What this trial is testing

Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Who this might be right for
Schizophrenic DisordersCognitive Function
Nathan Kline Institute for Psychiatric Research
Testing effectiveness (Phase 2)UnknownNCT02636244
What this trial is testing

Safety and Efficacy Study of SHAPE Gel in Alopecia Areata

Who this might be right for
Alopecia Areata
TetraLogic Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT02948075
What this trial is testing

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Ovarian Cancer
NewVac LLC 31
Testing effectiveness (Phase 2)Study completedNCT01037478
What this trial is testing

Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Hodgkin's Lymphoma
4SC AG 37
Early research (Phase 1)Study completedNCT00496444
What this trial is testing

Azacytidine and Valproic Acid in Patients With Advanced Cancers

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 69
Early research (Phase 1)Study completedNCT01464112
What this trial is testing

A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 18
Testing effectiveness (Phase 2)UnknownNCT03373019
What this trial is testing

Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
ChidamideLymphoma, B-CellLymphoma, Large B-Cell, Diffuse+13 more
Fudan University 63
Testing effectiveness (Phase 2)Study completedNCT00289952
What this trial is testing

Valproic Acid and Its Effects on HIV Latent Reservoirs

Who this might be right for
HIV Infections
Jean-Pierre Routy 50
Next Page